SCHEMBL16410872

SCHEMBL16410872

Fc1cccc2c1NC1(CCCCC1)C(NNCc1cccc(Cl)c1)=N2

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 1/20 0.35
▸ KMT2A Q03164 3/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ NOS3 P29474 2/20 0.33
▸ NOS1 P29475 2/20 0.33
▸ NOS2 P35228 2/20 0.33
▸ CCNT1 O60563 2/20 0.33
▸ CDK9 P50750 2/20 0.33
▸ MAPT P10636 1/20 0.32
▸ ALOX12 P18054 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ GHSR Q92847 2/20 0.31
▸ HTR2B P41595 1/20 0.31
▸ PDE7B Q9NP56 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17757462 0.90 CCNT1 (0.37) PDE7AKMT2ACYP3A4CYP2C19CYP2C9
SCHEMBL16410606 0.85 ACAT2 (0.40) PDE7AKMT2ACYP3A4CYP2C19CYP2C9
SCHEMBL16410779 0.82 CYP3A4 (0.35) CYP3A4CYP2C19CYP2C9NOS3NOS1
SCHEMBL16410782 0.81 ACAT2 (0.34) PDE7AKMT2ACYP3A4CYP2C19CYP2C9
SCHEMBL17757772 0.80 ACAT2 (0.41) KMT2ACCNT1CDK9HTR2B
SCHEMBL17757552 0.80 FABP4 (0.35) KMT2ACCNT1CDK9MEN1HTR2B
SCHEMBL16410559 0.80 NOS3 (0.34) PDE7AKMT2ACYP3A4CYP2C19CYP2C9
SCHEMBL16410840 0.80 ACAT2 (0.42) KMT2ANOS3NOS1NOS2MAPT
SCHEMBL17758043 0.80 PIK3CA (0.39) CYP3A4CYP2C19CCNT1CDK9CYP2D6
SCHEMBL17757476 0.79 PDE7A (0.38) PDE7AKMT2ACYP3A4CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback